MO704: Prognostic Factors of Serological Response to the Sars-Cov 2 Vaccine in Peritoneal Dialysis: Our Experience
| Autor: | Víctor Burguera Vion, R. Haridian Sosa Barrios, Jorge Sánchez Iglesias, Cristina Campillo Trapero, Yolanda Gutiérrez Martín, Elizabeth Viera Ramírez, Milagros Fernandez Lucas, Maite Rivera |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Nephrology Dialysis Transplantation. 37 |
| ISSN: | 1460-2385 0931-0509 |
| Popis: | BACKGROUND AND AIMS The severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) pandemic has had a massive impact in health systems worldwide, taking an important toll on dialysis patients as they are more comorbid, have higher mortality and an impaired immune system. Vaccines against SARS-Cov-2 proved to reduce mortality and hospitalization, but serological response in the dialysis population is weaker. Therefore, predictors of response would be useful to assess their level of protection and evaluate the need for further booster doses of the vaccine. METHOD RESULTS CONCLUSION In our experience, PD patients have an adequate serological response to the SARS-Cov-2 vaccines, being previous COVID exposure the main predictor of a good response. Conversely, longer duration of PD treatment was a prognostic factor of seroconversion failure. We believe this should be kept in mind to assess the need for booster vaccination doses in those patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|